Cancer remains our greatest health challenge, yet for too long, we have only reacted to it after symptoms appear. We are now entering a new era of proactive care. Genetic screening isn't just about predicting the future; it’s about gaining the "biological intelligence" needed to change it. In some individuals, the identification of specific markers today can unlock a personal roadmap for prevention. This personalised advice gives you the power to make smarter lifestyle choices and access treatment options as unique as your own DNA. Don’t wait for a diagnosis - use your genetic code to protect your future.
Why Choose Oncogenetic Screening?
Choosing Mediclinic’s Oncogenetic Package means taking a proactive step toward a healthier future by understanding your unique genetic makeup. Instead of waiting for symptoms to appear, this screening allows you to identify potential risks early, giving you and your doctors the vital information needed to create a personalised prevention plan. By turning uncertainty into a clear roadmap for your health, you gain the power to make informed decisions and take control of your well-being with the support of world-class medical expertise.
What is Oncogenetic Testing?
Genetic testing for cancer takes various forms depending on an individual's needs. Some tests are designed for healthy individuals seeking to "unlock" the information coded within their DNA through proactive screening programmes. Other tests are dedicated to resilient patients currently in the midst of their battle against cancer. This specific package is designed to help healthy individuals determine if they are predisposed to cancer-causing mutations. Genes are short segments of DNA that provide the essential instructions for how your body functions; however, these genes can sometimes undergo mutations, which may potentially increase the risk of developing cancer.
What is Next Generation Sequencing (NGS)?
NGS (Next-Generation Sequencing) Oncogenetic testing is an innovative technology that sequences exons - the specific parts of your genes containing the direct instructions that tell your body how to function. This advanced process analyses a person's known cancer-related exons to evaluate whether they are working correctly, as any mutations within these regions can cause or predispose individuals to certain diseases and specific health risks. Ultimately, NGS Oncogenetic testing allows your physician to obtain the most comprehensive picture of known genetic mutations, providing vital insights that may indicate or influence certain cancer conditions.
Specialist Consultation and Cancer Panel Testing
Screening for numerous different types of inherited cancers and other cancer-related multisystemic conditions.
What’s included:
- Specialist consultation
- Advanced cancer panel testing through Next Generation Sequencing (NGS)
- Follow-up consultation to discuss results and personalized treatment
Most common conditions screened for:
- Breast cancer risk
- Ovarian cancer risk
- Bowel and Colorectal cancer
- Familial Adenomatous Polyposis
- Uterine cancer (Endometrial cancer genes)
- Stomach cancer (Gastric cancer)
- Thyroid cancer (RET and other thyroid-related genes)
- Pancreatic cancer risk
- Prostate cancer
- Inherited skin cancer (Melanoma)
- Kidney cancer (Renal cancer)
Cancer-related Genetic Syndromes:
- Lynch syndrome
- TP53 – Li Fraumeni
- Von Hippel Lindau
- Multiple Endocrine Neoplasia Syndrome
- Cowden Syndrome (PTEN Hamartoma Tumor Syndrome)
- Peutz-Jeghers Syndrome
- Retinoblastoma
Book Your Appointment
Book your specialist consultation via the Mediclinic app, call 800 2033 or fill in the form below.